KardiaMobile 6L for measuring cardiac QT interval in adults having antipsychotic medication: early value assessment HTG694 26 September 2023 7 September 2026 Guided self-help digital cognitive ...
KardiaMobile 6L for measuring cardiac QT interval in adults having antipsychotic medication: early value assessment HTG694 26 September 2023 7 September 2026 Guided self-help digital cognitive ...
Mirdametinib for treating symptomatic and inoperable plexiform neurofibromas associated with neurofibromatosis type 1 in people 2 to 17 years [ID6618] In development GID-TA11819 Expected publication ...
This guideline has been updated and replaced by NICE rapid guideline on managing COVID-19 (NG191) ...
There is a simple discount patient access scheme for selumetinib. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisations can contact market.accessuk ...
Amivantamab with lazertinib for untreated EGFR mutation-positive advanced non-small-cell lung cancer
There are simple discount patient access schemes for amivantamab (Rybrevant) and lazertinib (Lazcluze). NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS ...
The recommendations in this guidance represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, health professionals are expected to ...
There is a simple discount patient access scheme for ribociclib. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisations can contact ...
Evidence-based recommendations on nivolumab with ipilimumab for previously treated metastatic colorectal cancer with high microsatellite instability or mismatch repair deficiency in adults. Next ...
Adults with a first episode of psychosis start treatment in early intervention in psychosis services within 2 weeks of referral. Early intervention in psychosis services can improve clinical outcomes, ...
Evidence-based recommendations on certolizumab pegol (Cimzia) for treating severe active rheumatoid arthritis in adults who have had a tumour necrosis factor-alpha inhibitor. Next review: This ...
This guidance has been updated and replaced by NICE technology appraisal guidance 946 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results